Retro Biosciences Starts a Safety Trial for an Autophagy Promoter
Retro Biosciences has initiated a Phase 1 safety trial of its small‑molecule autophagy promoter RTR242 in healthy volunteers in Australia. The drug is designed to restore lysosomal acidity, thereby enhancing cellular waste‑clearance mechanisms that decline with age. The study is randomized, double‑blind and placebo‑controlled, incorporating exploratory biomarkers to gauge autophagy activation. If successful, the approach could broaden longevity therapeutics and address neurodegenerative disease pathways.
Market Unconvinced: KYRS Needs Functional Data
$KYRS +1% Nice science, market not convinced. KB407 shows delivery + CFTR protein in bronchoscopic biopsies, but no sweat chloride/NPD/FEV1. End of day, PD != clinical translation. Also a crowded CF GTx race = priced in. $FDMT 4D-710 (ppFEV1/LCI signals),...
Evaluating Sarcopenia Criteria for Fall Prediction in Seniors
A recent cohort study examined multiple sarcopenia diagnostic criteria to determine which best predicts falls among seniors aged 65 and older. Researchers compared the European Working Group on Sarcopenia in Older People (EWGSOP2) algorithm, the SARC‑F questionnaire, and simple performance...
Mapping Prenatal Microbial Diversity in Amniotic Fluid
A new study has produced the first comprehensive map of microbial diversity in amniotic fluid, challenging the long‑held belief that the intrauterine environment is sterile. Researchers analyzed over 500 samples using ultra‑sensitive metagenomic sequencing, identifying a low‑biomass but distinct bacterial...
Gene Editing Pioneers Launch First Startup Focused on Custom CRISPR Therapies
A team of leading gene‑editing scientists has launched a new startup dedicated to developing custom CRISPR therapies for individual patients. The company builds on a landmark case last spring where researchers engineered a bespoke CRISPR treatment to correct a rare...
A New CRISPR Startup Is Betting Regulators Will Ease up on Gene-Editing
A new CRISPR startup, Aurora Therapeutics, aims to secure regulatory approval for a single, modular gene‑editing platform that can be tweaked for multiple mutations. Backed by $16 million from Menlo Ventures and advised by CRISPR co‑inventor Jennifer Doudna, Aurora’s first target...
Report Says MSD Is in Talks to Buy Revolution Meds
Financial Times reports MSD is in advanced talks to acquire Revolution Medicines in a deal valued between $28 billion and $32 billion, potentially the largest pharma merger since Pfizer's Seagen purchase. The announcement sent Revolution’s shares up 16% in pre‑market trading, giving...
Study Finds Food Waste Compost Less Effective than Potting Mix Alone
Researchers at the University of Arkansas evaluated food‑waste compost as a growing substrate for tomato and watermelon seedlings. The study, published in HortTechnology, found that pure food‑waste compost performed worse than standard peat‑based potting mix, while blends containing less than...
Bone Marrow Immune Cell Map Boosts Survival, Relapse Prediction in Multiple Myeloma
Researchers created a single‑cell immune atlas of bone‑marrow cells from 337 newly diagnosed multiple myeloma patients, profiling nearly 1.4 million plasma and immune cells. The study, published in Nature Cancer, links specific immune cell populations and signaling pathways to rapid relapse...
New Single‑Cell Testing Measures How Effectively Antibiotics Kill Bacteria
Researchers at the University of Basel introduced Antimicrobial Single‑Cell Testing (ASCT), a high‑throughput live‑cell imaging platform that quantifies antibiotic killing at single‑cell resolution. By dispensing bacteria into 1,536‑well plates and tracking up to one million images per experiment, the team...
M Ventures: Pharma CVC and Biotech Innovation in 2026
Merck KGaA’s corporate venture arm, M Ventures, opened 2026 with Managing Director Hakan Goker outlining its 2025 successes and 2026 priorities. The CVC highlighted marquee investments such as FoRx Therapeutics and Artios, which earned an FDA Fast Track designation, and...
Higher Consumption of Food Preservatives Is Associated with an Increased Risk of Type 2 Diabetes
Researchers from Inserm and partner institutions analyzed data from over 100,000 French adults in the NutriNet‑Santé cohort and found that higher consumption of food preservatives—both non‑antioxidant and antioxidant types—was linked to a 40‑49% increased incidence of type 2 diabetes. The study...
Dr. Marty Makary Was Paid $130,357 By Pharma. Is His “Undue Influence” Affecting the FDA?
Dr. Marty Makary, now FDA commissioner, earned $130,357 from pharma firms before his nomination and serves on the board of an ophthalmic drug company despite pledging never to work for big‑pharma. He appointed former industry executive Dr. George Tidmarsh to...
R-Loops Drive RNAPII Reprogramming in Early Development
A new study reveals that R‑loops, three‑strand nucleic‑acid structures, actively reprogram RNA polymerase II (RNAPII) positioning during early embryonic development. Genome‑wide mapping in mouse zygotes shows that 30% of RNAPII peaks coincide with R‑loop sites, directing transcription toward lineage‑specific genes....
Youth Sarcopenia and Body Composition via Bioimpedance
A new study published on Bioengineer.org reveals that bioimpedance analysis (BIA) can reliably detect sarcopenia and altered body composition in adolescents. Researchers evaluated over 1,200 youths aged 12‑19, finding a 7.4% prevalence of low muscle mass that exceeds prior estimates...
CircRNA14781 Drives Olaparib Resistance in Ovarian Cancer
Researchers identified circular RNA circRNA14781 as a key driver of olaparib resistance in high‑grade ovarian cancer. The non‑coding RNA is markedly overexpressed in tumor samples that fail PARP‑inhibitor therapy and functions by sponging tumor‑suppressive microRNAs, thereby re‑activating DNA‑repair pathways. In...
Mapping Eucalyptus Genes for Phosphate Transport Efficiency
Researchers have completed a high‑resolution map of eucalyptus genes that control phosphate transport, pinpointing dozens of candidate transporters. Expression profiling shows several genes surge when trees face low‑phosphate soils, suggesting natural efficiency mechanisms. The team demonstrated CRISPR‑mediated edits that boost...
Chlorella Nanogels Suppress Lung Injury Inflammation
Researchers have engineered chlorella‑derived nanogels that markedly suppress inflammation in experimental lung injury. In murine models, the nanogels lowered pro‑inflammatory cytokines, reduced alveolar edema, and improved survival rates. The delivery platform leverages the natural biocompatibility of chlorella polysaccharides to target...
2025 FDA Approvals: Innovation Holds Steady in First Year Under New Leadership
Under the FDA’s new leadership, 2025 saw the approval of 46 new molecular entities and 10 new biologics, matching the pace of recent years. The agency’s review process remained on schedule, suggesting that the transition in senior management has not...
Independent Low-Cost Vaccines Keep Pfizer Out of Markets
ANS: I don’t take a dime from Pfizer or any other big pharma company. If and when you decide to visit a library instead of relying on conspiracy sites, you’ll find we develop low cost, patent free vaccines that bypass...
Albendazole’s Impact on Helminths in Yunnan Kids
Researchers evaluated a school‑based albendazole deworming program among 3,200 children aged 5‑12 in Yunnan province. Baseline surveys showed a 42% helminth infection rate, which fell to 13% after a single annual dose. The intervention also correlated with modest gains in...
JPM Acts as Audit, Reveals Biotech Translation Friction
JPM Isn’t a Conference. It’s an Audit. What 1,000 companies and 6 years of data quietly tell you about biotech translation. Part 1. Why you should care. JPM decides who looks fundable before a single new dataset drops. That sounds backward, but it...
OpenAI Brings ChatGPT to Hospitals on the Heels of Launching Consumer Health Tool
OpenAI unveiled ChatGPT for Healthcare, extending its popular conversational AI into hospitals and health systems. The offering follows the recent launch of a consumer‑focused health tool, signaling a broader push into clinical environments. OpenAI says the service will integrate with...
Expert Consensus on Validating Internal Jugular Ultrasound Tool
A panel of leading emergency physicians, intensivists, and radiologists released an expert consensus outlining a structured validation pathway for internal jugular vein ultrasound (IJU) tools. The framework delineates three validation phases—technical performance, operator reproducibility, and clinical outcome impact—backed by specific...
Evaluating Acupuncture for Cancer Treatment Fatigue: A Review
A recent systematic review examined acupuncture as a therapeutic option for cancer‑related fatigue, analyzing data from 18 randomized controlled trials involving over 2,000 patients. The analysis found that acupuncture produced modest but statistically significant reductions in fatigue severity compared with...
New Framework Enhances Climate Health Vulnerability Analysis
A multidisciplinary research team has unveiled a new analytical framework that fuses high‑resolution climate data with population health metrics to assess climate‑related health vulnerability. The platform leverages machine‑learning‑driven spatial modeling, incorporating temperature, air‑quality, and socioeconomic indicators to predict disease risk...
Investors Now Require Clean Data and Clear Milestones
From Proof to Payoff | Ep. 900 2025 changed biotech translation. Capital came back with rules. No data, no money. Clean data, financing opens. If your next readout doesn’t force a decision, you stall, no matter how pretty the biology looks. What the market pays for...
Baby KJ Scientist Launches Startup to Scale Personalized CRISPR Therapies
Key scientist from Baby KJ team launches startup to scale personalized CRISPR medicines https://t.co/7RY4SKrx9Y via @Jasonmmast @ADeAngelis_bio
Microbial Communities and Tight Junctions in Cattle’s Gut
A new study links specific microbial communities to the integrity of tight junction proteins in the bovine gut, showing that a higher abundance of *Ruminococcus* and *Lactobacillus* correlates with stronger barrier function. Metagenomic sequencing and intestinal tissue analysis revealed a...
Know the FDA Process: Key to Biotech Investment Success
Investors should understand the #FDA regulatory process well. Here is a quick summary At each step investors should ask themselves if the company is developing things in a way that will satisfy the FDA Until a drug is approved the FDA is...
Deformable Adjuvants Can Enhance Immune Activation in New Vaccine Design
Researchers at the Chinese Academy of Sciences have engineered aluminum‑stabilized Pickering emulsions (ASPE) that act as deformable adjuvants, providing mechanical cues to dendritic cells. By adjusting nanoparticle crystallinity, the interfacial stiffness can be tuned to activate the mechanosensitive PIEZO1 channel,...
Aberrant Calcium Signaling and Neuronal Activity in the L271H CACNA1D (Cav1.3) iPSC Model of Neurodevelopmental Disease
Researchers created the first patient‑derived iPSC model carrying the de novo L271H CACNA1D (Ca_v1.3) variant linked to neurodevelopmental disease. The study shows that Ca_v1.3 is the dominant L‑type calcium channel in neural progenitor cells, where the mutation drives heightened spontaneous calcium...
TIGIT Disruption Boosts Low-Avidity T Cell Tumor Attack
Researchers have demonstrated that genetic disruption of the inhibitory receptor TIGIT markedly amplifies the anti‑tumor activity of low‑avidity T cells. In mouse models, TIGIT‑deficient T cells infiltrated tumors more efficiently and induced significant tumor regression, especially when paired with existing...
WRKY Gene Family’s Role in Cucurbita Moschata Resistance
Researchers have identified specific WRKY transcription factors that enhance disease resistance in Cucurbita moschata, commonly known as winter squash. Using genome‑wide association studies and CRISPR‑mediated knock‑outs, the team pinpointed WRKY45 and WRKY70 as key regulators against Phytophthora blight. Field trials...
Noncanonical TRPM4 Controls Intestinal Fluid Balance
Researchers have identified a noncanonical isoform of the TRPM4 ion channel that directly regulates intestinal fluid secretion and absorption. Using mouse models and human intestinal organoids, the study showed that loss of this isoform leads to dysregulated electrolyte transport and...
METTL3 Loss Drives Glioma via Macrophage Lipids
Researchers have discovered that loss of the RNA methyltransferase METTL3 accelerates glioma progression by reprogramming macrophage lipid metabolism. The study shows METTL3‑deficient tumor cells induce lipid accumulation in tumor‑associated macrophages, creating an immunosuppressive microenvironment that fuels tumor growth. Mechanistic analysis...
Designing Liver Simulants with Hyperelastic Micromechanics
On January 9, 2026 Bioengineer.org published a suite of research highlights spanning nanomedicine, parasitology, medical imaging, climate‑health analytics, and plant genetics. The pieces report that chlorella‑based nanogels markedly suppress lung injury inflammation, albendazole effectively reduces helminth burdens in Yunnan children, and an...
Merck in Talks to Acquire Revolution Medicines, Deal Uncertain
Our man @mroliverbarnes $MRK $RVMD https://t.co/vUssAaRo5e US pharmaceutical group Merck is in talks to buy Revolution Medicines, a cancer drugmaker with a market capitalisation of nearly $19bn, in what would be the latest big deal in the red-hot biotechnology...
Zanidatamab Plus Tislelizumab Raises Diarrhea Risk
#GI26 zanidatamab/chemo ± tislelizumab in the HERIZON-GEA-01 trial: not much attention on side effect profile. If you combine zani, tisle and 5FU you will get more diarrhea/discontinuations https://t.co/55aDi7Pnpx
Sanofi Calls Rejection of Potential MS Blockbuster 'Unexpected'
Sanofi announced that the FDA rejected its experimental multiple‑sclerosis therapy, labeling the decision unexpected. The agency raised substantive questions late in the review process, leaving insufficient time for Sanofi to amend its submission. The setback threatens the anticipated launch of...
Multi-Omic Atlas Shows Women’s Stronger Immunity, Age‑Related Decline
We're learning more about our immune system from a new, comprehensive, multi-omic atlas in @ScienceMagazine today, such as the stronger immune system in women and the age-related features of immunosenescence https://t.co/4B85BwohBb https://t.co/DHNIUKcQmE
Illumina Hires Eric Green as Chief Medical Officer
Illumina announced the appointment of Eric Green, former director of the National Human Genome Research Institute and a pioneering geneticist, as its new chief medical officer. Green will lead the company’s clinical strategy, regulatory affairs, and diagnostic product development. The...
How Light Reflects on Leaves May Help Researchers Identify Dying Forests
Researchers at the University of Notre Dame have demonstrated that leaf spectral reflectance measured from airborne or satellite sensors can predict the expression of key stress‑related genes. By sampling sugar maple and red maple leaves in Wisconsin and Michigan, they...
AlphaFold Sparks Surge in Genome-Wide Drug Discovery
In the post-AlphaFold era, drug discovery is on a tear —Genome-wide virtual screening @ScienceMagazine https://t.co/GPyjSK6PcM —Transforming the industry in many ways @TheEconomist https://t.co/ppAMkbFqMp
Stem Cell-Derived Neurons Navigate to Form Connections in the Injured Brain
Researchers at Sanford Burnham Prebys and Duke‑NUS have demonstrated that human embryonic stem cell‑derived cortical neurons can be grafted directly into the lesion cavity of mice after ischemic stroke, survive, mature into NeuN‑positive neurons, and re‑establish long‑range connections. By tracing...
In Search of Mechanisms to Explain the Sex Difference in Alzheimer's Disease Outcomes
Recent open‑access research confirms that women experience more severe Alzheimer’s pathology than men, with female 5xFAD mice developing larger, less compact amyloid‑β plaques. Transcriptomic analysis revealed that female microglia up‑regulate glycolytic metabolism, antigen‑presentation pathways, and a distinct type‑I interferon signature,...
Science Spotlight: Thwarting Melanoma Immune Evasion
Researchers have uncovered new molecular pathways that melanoma cells use to dodge immune surveillance, focusing on PD‑L1 up‑regulation and downstream signaling. A high‑throughput CRISPR‑Cas9 screen pinpointed several previously unknown evasion genes, enabling a targeted combination‑therapy approach. Early‑phase trials combining checkpoint...
FDA Staff Cuts Mostly Didn't Impact New Drug Review Timelines, Analysis Finds
Despite thousands of staff cuts, retirements, and leadership departures at the FDA in 2025, the agency’s drug reviewers largely maintained their review schedules. An internal analysis shows that median approval times for new molecular entities shifted by less than one...
Healing Brain Cells and Tackling Neurodegenerative Diseases with Nanoflowers
Researchers at Texas A&M have shown that metallic “nanoflower” nanoparticles can protect and repair brain cells by improving mitochondrial health. In cell cultures, the nanoflowers sharply lowered reactive oxygen species and enhanced mitochondrial integrity within a day, and in C....
Lilly Tests Zepbound to Drive Taltz Sales
$LLY runs a psoriatic arthritis marketing study of Zepbound hoping to boost sales of Taltz. @elaineywchen sees right through it. Eli Lilly’s Zepbound, on top of immunology drug, helped reduce psoriatic arthritis symptoms https://t.co/pcmEhIZgWY